Data compiled by Redley Lamar · ChainSifter Intelligence
6Suppliers
3Customers
2Debt Items
12Related Chains
Source-Backed Evidence Depth
Nkarta, Inc. (NKTX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
12Total relationships
4Distinct source URLs
7High confidence
0.802Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Nkarta, Inc. Suppliers
Ticker
Name
Confidence
Evidence
LICENSORS
LICENSORS
92%
Payments to the Licensors pursuant to the license agreement include single-digit royalty payments on commercial sales, a portion of any sublicensing revenue, patent expenses, license maintenance fees…
THIRD-PARTY-CONTRACT-MANUFACTURING-SITES
THIRD-PARTY-CONTRACT-MANUFACTURING-SITES
90%
we currently manufacture clinical supply of NKSTIM cells and the gamma-retrovirus at third-party contract manufacturing sites.
NATIONAL-UNIVERSITY-OF-SINGAPORE
NATIONAL-UNIVERSITY-OF-SINGAPORE
80%
If our license agreement with National University of Singapore and St. Jude Children’s Research Hospital, Inc. is terminated, we could lose our rights to key components enabling our NK-cell engineeri…
ST-JUDE-CHILDREN-S-RESEARCH-HOSPITAL-INC
ST-JUDE-CHILDREN-S-RESEARCH-HOSPITAL-INC
80%
If our license agreement with National University of Singapore and St. Jude Children’s Research Hospital, Inc. is terminated, we could lose our rights to key components enabling our NK-cell engineeri…
Reciprocal relationship from CRSP graph: Reciprocal relationship from NKTX graph: Item 1A. Risk Factors. An investment in shares of our common stock involves a high degree of risk. You should careful…
Item 1A. Risk Factors. An investment in shares of our common stock involves a high degree of risk. You should carefully consider the following risk factors, as well as all of the other information co…
Reciprocal relationship from CRSP graph: Reciprocal relationship from NKTX graph: Item 1A. Risk Factors. An investment in shares of our common stock involves a high degree of risk. You should careful…
Item 1A. Risk Factors. An investment in shares of our common stock involves a high degree of risk. You should carefully consider the following risk factors, as well as all of the other information co…
RESEARCH-HOSPITAL-INC
RESEARCH-HOSPITAL-INC
62%
ary statements. i RISK FACTOR SUMMARY Below is a summary of material factors that make an investment in our common stock speculative or risky. Importantly, this summary does not address all the risks…
Nkarta, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NKTX-DEBT
Debt stack $75.0M
90%
Market cache reports total debt of $75.0M.
NKTX-DEBT-11283
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
Nkarta, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Nkarta, Inc..
Nkarta, Inc. Ownership
Holder
Name
Confidence
Evidence
NKTX-OWNER-RA-CAPITAL-MANAGEMENT-L-P
RA CAPITAL MANAGEMENT, L.P.
90%
13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 125 tracked holders.
